Umoja Biopharma, Inc.
Biotechnology company · Seattle, Washington, United States
Umoja Biopharma, Inc. is a biotechnology company headquartered in Seattle, Washington, United States. Its earliest recorded incorporation is in 2019. It has reported private securities offerings to the US SEC, most recently $210 million sold in a notice filed in 2021.
Umoja Biopharma at a glance
What does Umoja Biopharma do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $210 million sold (2021).
Frequently asked questions about Umoja Biopharma
Where is Umoja Biopharma headquartered?
Umoja Biopharma, Inc. is headquartered in Seattle, Washington, United States.
What does Umoja Biopharma do?
Umoja Biopharma, Inc. is a biotechnology company.
When was Umoja Biopharma founded?
The earliest incorporation on record for Umoja Biopharma, Inc. is in 2019, according to public company registers.
Similar companies
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Kineta, Inc.Seattle, Washington, United States
- Avm Biotechnology, LLCSeattle, Washington, United States
- Lumen Bioscience, Inc.Seattle, Washington, United States
- Presage Biosciences, Inc.Seattle, Washington, United States
- Sana Biotechnology, Inc.Seattle, Washington, United States
- Phase Genomics, Inc.Seattle, Washington, United States
- Soovu Labs, Inc.Seattle, Washington, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences